Your browser doesn't support javascript.
loading
Smoking and quality of life in lung cancer patients: systematic review.
Halms, Theresa; Strasser, Martina; Hasan, Alkomiet; Rüther, Tobias; Trepel, Martin; Raab, Stephan; Gertzen, Marcus.
Afiliación
  • Halms T; Department of Psychiatry and Psychotherapy, Medical Faculty, University of Augsburg, Augsburg, Germany theresa.halms@med.uni-augsburg.de.
  • Strasser M; Department of Psychiatry and Psychotherapy, Medical Faculty, University of Augsburg, Augsburg, Germany.
  • Hasan A; Department of Psychiatry and Psychotherapy, Medical Faculty, University of Augsburg, Augsburg, Germany.
  • Rüther T; Department of Psychiatry and Psychotherapy, University Hospital, Ludwig­Maximilians University Munich, Munich, Germany.
  • Trepel M; Department of Hematology and Oncology, Medical Faculty, University of Augsburg, University Hospital Augsburg, Augsburg, Germany.
  • Raab S; Comprehensive Cancer Center Augsburg (CCCA), Augsburg, Germany.
  • Gertzen M; Department of Thoracic Surgery, University Hospital Augsburg, Augsburg, Germany.
BMJ Support Palliat Care ; 13(e3): e686-e694, 2024 Jan 08.
Article en En | MEDLINE | ID: mdl-37607808
ABSTRACT

OBJECTIVES:

Lung cancer (LC) accounts for the largest number of cancer deaths worldwide, with smoking being the leading cause for its development. While quality of life (QoL) is a crucial factor in the treatment of patients with LC, the impact of smoking status on QoL remains unclear. This systematic review aims to provide a comprehensive overview of available evidence on the relationship between smoking status and QoL among patients with LC.

METHODS:

A systematic search of Embase, Medline and Web of Science was conducted. Studies reporting the impact of smoking status on QoL among patients with LC were eligible for inclusion. Two reviewers independently assessed the eligibility of studies, extracted data and evaluated the risk of bias using the Critical Appraisal Skills Programme appraisal tool for cohort studies. A descriptive synthesis was performed due to the heterogeneity of the studies.

RESULTS:

A total of 23 studies met the inclusion criteria (17 studies providing cross-sectional and 6 longitudinal data). The studies included a total of 10 251 participants. The results suggested a tendency towards lower QoL among smokers compared with non-smokers. The effect of smoking cessation on QoL was insufficiently investigated in the included studies and therefore remains inconclusive.

CONCLUSIONS:

The findings of this review suggest that current smokers may experience worse QoL than former and never smokers. The results of this systematic review should, however, be viewed in the context of the difficulty of data collection in this patient group given the low survival rates and low performance status, among other factors and in light of the large variety of different QoL measures used. Future research requires uniform QoL measures, a holistic representation of all patients with LC as well as a comprehensive consideration of all potential determinants of QoL. The potential benefits of smoking cessation on QoL among patients with LC require investigation.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cese del Hábito de Fumar / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Risk_factors_studies / Systematic_reviews Aspecto: Patient_preference Límite: Humans Idioma: En Revista: BMJ Support Palliat Care Año: 2024 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cese del Hábito de Fumar / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Risk_factors_studies / Systematic_reviews Aspecto: Patient_preference Límite: Humans Idioma: En Revista: BMJ Support Palliat Care Año: 2024 Tipo del documento: Article País de afiliación: Alemania